TrialBlood2015

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.

Daniel O Persky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.